These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30903640)

  • 81. Selection and characterization of tenascin C targeting peptide.
    Kim MY; Kim OR; Choi YS; Lee H; Park K; Lee CT; Kang KW; Jeong S
    Mol Cells; 2012 Jan; 33(1):71-7. PubMed ID: 22138765
    [TBL] [Abstract][Full Text] [Related]  

  • 82. New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
    Debinski W; Dickinson P; Rossmeisl JH; Robertson J; Gibo DM
    PLoS One; 2013; 8(10):e77719. PubMed ID: 24147065
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeting of IL-4 and IL-13 receptors for cancer therapy.
    Suzuki A; Leland P; Joshi BH; Puri RK
    Cytokine; 2015 Sep; 75(1):79-88. PubMed ID: 26088753
    [TBL] [Abstract][Full Text] [Related]  

  • 84. TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.
    Badalyan V; Thompson R; Addo K; Borthwick LA; Fisher AJ; Ort T; Myers TG; Wynn TA; Ramalingam TR
    J Allergy Clin Immunol; 2014 Oct; 134(4):975-8.e5. PubMed ID: 24954262
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.
    Lupardus PJ; Birnbaum ME; Garcia KC
    Structure; 2010 Mar; 18(3):332-42. PubMed ID: 20223216
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.
    Matsuo AL; Tanaka AS; Juliano MA; Rodrigues EG; Travassos LR
    J Mol Med (Berl); 2010 Dec; 88(12):1255-64. PubMed ID: 20802991
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma.
    Joshi BH; Puri RA; Leland P; Varricchio F; Gupta G; Kocak M; Gilbertson RJ; Puri RK;
    Neuro Oncol; 2008 Jun; 10(3):265-74. PubMed ID: 18430795
    [TBL] [Abstract][Full Text] [Related]  

  • 88. IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.
    Nguyen V; Conyers JM; Zhu D; Gibo DM; Dorsey JF; Debinski W; Mintz A
    Transl Oncol; 2011 Dec; 4(6):390-400. PubMed ID: 22191003
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.
    Yin Y; Boesteanu AC; Binder ZA; Xu C; Reid RA; Rodriguez JL; Cook DR; Thokala R; Blouch K; McGettigan-Croce B; Zhang L; Konradt C; Cogdill AP; Panjwani MK; Jiang S; Migliorini D; Dahmane N; Posey AD; June CH; Mason NJ; Lin Z; O'Rourke DM; Johnson LA
    Mol Ther Oncolytics; 2018 Dec; 11():20-38. PubMed ID: 30306125
    [TBL] [Abstract][Full Text] [Related]  

  • 90. IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
    Chen W; Sivaprasad U; Tabata Y; Gibson AM; Stier MT; Finkelman FD; Hershey GK
    J Immunol; 2009 Dec; 183(12):7870-6. PubMed ID: 20007572
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors.
    Fillmore HL; Shultz MD; Henderson SC; Cooper P; Broaddus WC; Chen ZJ; Shu CY; Zhang J; Ge J; Dorn HC; Corwin F; Hirsch JI; Wilson J; Fatouros PP
    Nanomedicine (Lond); 2011 Apr; 6(3):449-58. PubMed ID: 21542684
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin.
    Liu TF; Cai J; Gibo DM; Debinski W
    Clin Cancer Res; 2009 Jan; 15(1):160-8. PubMed ID: 19118043
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts.
    Penke LR; Ouchi H; Speth JM; Lugogo N; Huang YJ; Huang SK; Peters-Golden M
    Sci Rep; 2020 Jan; 10(1):1083. PubMed ID: 31974428
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Characterization and immunotherapeutic implications for a novel antibody targeting interleukin (IL)-13 receptor α2.
    Balyasnikova IV; Wainwright DA; Solomaha E; Lee G; Han Y; Thaci B; Lesniak MS
    J Biol Chem; 2012 Aug; 287(36):30215-27. PubMed ID: 22778273
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Targeting glioblastoma multiforme using a novel fusion protein comprising interleukin-13 and staphylococcal enterotoxin B in vitro.
    Gholipour Z; Fooladi AAI; Parivar K; Halabian R
    Toxicol In Vitro; 2023 Oct; 92():105651. PubMed ID: 37482138
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.
    Steinstraesser L; Hauk J; Schubert C; Al-Benna S; Stricker I; Hatt H; Shai Y; Steinau HU; Jacobsen F
    PLoS One; 2011 Mar; 6(3):e18321. PubMed ID: 21483840
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
    Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175
    [TBL] [Abstract][Full Text] [Related]  

  • 98. killerFLIP: a novel lytic peptide specifically inducing cancer cell death.
    Pennarun B; Gaidos G; Bucur O; Tinari A; Rupasinghe C; Jin T; Dewar R; Song K; Santos MT; Malorni W; Mierke D; Khosravi-Far R
    Cell Death Dis; 2013 Oct; 4(10):e894. PubMed ID: 24176852
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selection and identification of novel peptides specifically targeting human cervical cancer.
    Liu X; Peng J; He J; Li Q; Zhou J; Liang X; Tang S
    Amino Acids; 2018 May; 50(5):577-592. PubMed ID: 29435721
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The role of interleukin-13 in the removal of hyper-radiosensitivity by priming irradiation.
    Edin NF
    J Radiat Res; 2014 Nov; 55(6):1066-74. PubMed ID: 24966400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.